申请人:Relay Therapeutics, Inc.
公开号:US20210085677A1
公开(公告)日:2021-03-25
The disclosure is in part directed to crystalline forms of (R)-1′-(3-(3,4-dihydro-1,5-naphthyridin-1(2H)-yl)-1H-pyrazolo[3,4-b]pyrazin-6-yl)-3H-spiro[benzofuran-2,4′-piperidin]-3-amine, its salt, and variants thereof.
该披露部分涉及(R)-1'-(3-(3,4-二氢-1,5-萘啶并[1,2-2H]-基)-1H-吡唑并[3,4-b]吡嗪-6-基)-3H-螺[苯并呋喃-2,4'-哌啶]-3-胺的结晶形式,其盐和其变体。